Nishikawa T, Dohi S
Department of Anaesthesiology, University of Tsukuba, Ibaraki, Japan.
Can J Anaesth. 1993 Feb;40(2):142-53. doi: 10.1007/BF03011312.
Cardiac output (CO) determination by thermodilution, which was introduced by Fegler in 1954, has gained wide acceptance in clinical medicine and animal experiments because it has several advantages over other methods with respect to simplicity, accuracy, reproducibility, repeated measurements at short intervals, and because there is no need for blood withdrawal. However, errors in determination of CO by thermodilution may be introduced by technical factors and the patients' pathological conditions. The current review summarizes these issues and provides our recommendations, based on the medical literature published between 1954-1992. To obtain more reproducible and accurate CO values by thermodilution, one should make several determinations (1) by using 10 ml injectate at room temperature for adults and 0.15 ml.kg-1 injectate for infants and children; (2) at evenly spaced intervals of the ventilation cycle; (3) when rapid intravenous fluid administration is discontinued; (4) by observing thermodilution curves so that baseline pulmonary artery temperature drift or the existence of intra- and extracardiac shunts are noticed. Finally, CO determination by thermodilution may be unreliable or impossible in patients with low CO states and tricuspid or pulmonary regurgitation. Since non-invasive CO monitoring has not replaced CO determination by thermodilution, intimate knowledge of this method is crucial for anaesthetists to prevent errors in the management of patients.
热稀释法测定心输出量由费格勒于1954年提出,因其在简便性、准确性、可重复性、短时间间隔内重复测量等方面优于其他方法,且无需采血,已在临床医学和动物实验中得到广泛认可。然而,热稀释法测定心输出量时可能会因技术因素和患者病理状况而产生误差。本综述总结了这些问题,并根据1954年至1992年间发表的医学文献提供了我们的建议。为通过热稀释法获得更可重复和准确的心输出量值,应进行多次测定:(1)成人使用室温下10毫升注射剂,婴儿和儿童使用0.15毫升/千克注射剂;(2)在通气周期的等间隔时间;(3)在快速静脉输液停止时;(4)通过观察热稀释曲线,以便注意到肺动脉温度基线漂移或心内和心外分流的存在。最后,在低心输出量状态以及三尖瓣或肺动脉反流患者中,热稀释法测定心输出量可能不可靠或无法进行。由于无创心输出量监测尚未取代热稀释法测定心输出量,因此麻醉医生深入了解该方法对于防止患者管理中的错误至关重要。